Benzinga | Apr 12, 2021 08:01AM EDT

Masimo Announces FDA Clearance Of Radius PCG For Root Patient Monitoring And Connectivity Platform

Masimo (NASDAQ:MASI) announced today that Radius PCG(tm), a portable real-time capnograph with wireless Bluetooth(r) connectivity, has received FDA 510(k) clearance. Radius PCG connects with the Root(r) Patient Monitoring and Connectivity Platform to provide seamless, tetherless mainstream capnography for patients of all ages. Radius PCG joins the growing family of tetherless Masimo technologies that includes Radius PPG(tm), which offers Masimo SET(r) Measure-through Motion and Low Perfusion pulse oximetry, and Radius T?(tm), which provides continuous temperature measurements. Radius PCG requires no routine calibration, with accurate end-tidal carbon dioxide (EtCO2) and respiration rate measurements and continuous EtCO2 waveforms displayed within 15 seconds--all in a small, portable package that can fit in the palm of a hand.